News about Cancer

Lars Hvass is BRIDGE Fellow

Postdoc Lars Hvass has recently been named BRIDGE Fellow. The title of his project is “Pre-targeted Radioligand Therapy of Breast Cancer Brain Metastases”.

Cancer patients experience fewer complications with help from artificial intelligence

Patients who have undergone surgery for colorectal cancer experience fewer serious complications and fewer readmissions when an AI tool supports treatment decisions.

Research in the development of blood stem cells receives international recognition

Professor Ana Cvejic was recently elected as member of EMBO, European Molecular Biology Organization, in recognition of her outstanding achievements and research excellence.

Supercomputer and AI to boost Danish cancer treatment – new project awarded €7 million

With a grant of over €7 million from the Novo Nordisk Foundation’s Grand AI Challenge, the AIM@CANCER project will enable researchers to harness the vast amounts of imaging data generated during radiation therapy for…

More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method

A new gene-editing method enables researchers to more easily determine whether a patient has inherited an increased risk of developing cancer—before any symptoms appear. Researchers at Rigshospitalet have tested the…

More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method

A new gene-editing method enables researchers to more easily determine whether a patient has inherited an increased risk of developing cancer—before any symptoms appear. Researchers at Rigshospitalet have tested the…

Enciso-Martinez A et al. J Extracell Vesicles 14: e70106, 2025

Team OF-BIOMARKER/ BIOENGINEERING/ OF-CANCER paper published

Lauritz Brorsen wins AI Award for innovative skin cancer project

Postdoc Lauritz Brorsen recently won the AI Award at the AI and Pharmacology – now and in the future symposium hosted by Altinget 3 June.

Scientific breakthrough: We can now halve the price of costly cancer drug

The demand for the widely used cancer drug Taxol is increasing, but it’s difficult and expensive to produce because it hasn’t been possible to do it biosynthetically. Until now, that is. Researchers from the University…

New research reveals how cancer drugs impact cells at the molecular level

A University of Copenhagen study uncovers intricate details about protein function at the molecular level. The discovery could transform disease diagnostics and treatment.

New research reveals how cancer drugs impact cells at the molecular level

A University of Copenhagen study uncovers intricate details about protein function at the molecular level. The discovery could transform disease diagnostics and treatment.

Zhao Y et al. J Extracell Vesicles 14: e70067, 2025

Team OF-BIOMARKER/ BIOENGINEERING/ OF-CANCER paper published

Nanna Skeltved

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Tang J et al. STAR Protoc 6: 103635, 2025

Team OF-BIOMARKER/ BIOENGINEERING/ OF-CANCER paper published

Living a Cancer Surveillance Life

Professor Ayo Wahlberg has together with Julie I. P. Gislinge, Anna Byrjalsen, Klara V. Naver, Helle V. Clausen, Pernille Ravn, Kresten R. Petersen and Karin Wadt co-written the article 'Living a Cancer Surveillance…

School-based social and educational support for siblings of children with cancer

Ph.D. student Minna Devantier and Professor Ayo Wahlberg has together with a team of researchers specialized in childhood cancer published an article.

New effective treatment for deadly cancer may be on its way

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research from the University of Copenhagen and Rigshospitalet shows. It has the potential to increase…

New effective treatment for deadly cancer may be on its way

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research from the University of Copenhagen and Rigshospitalet shows. It has the potential to increase…

Researchers can now identify cancer cells leading to tumor recurrence

Cancer cells escaping tumors in the brain avoid surgery and create new recurrent tumors, but now researchers from the University of Copenhagen and Rigshospitalet have identified and characterized these cells. This can…

Jaroentomeechai T et al. Nat Commun 15: 9668, 2024

Team OF-CANCER paper published

BRIC researcher participates in prime-time TV-show to explain how fundamental research can help cancer patients

This year, Fena Ochs, is part of the “Knæk Cancer” fundraising show by the Danish Cancer Society and Danish TV-channel TV2. She shows how Knæk Cancer supports her research in breast- and ovarian cancer.

AI could predict breast cancer risk via ‘zombie cells’

Research from the University of Copenhagen shows that new AI technology is better at predicting the risk of breast cancer than current clinical benchmarks.

Now we know why children with Down’s syndrome have higher risk of Leukemia

People with Down’s syndrome face a higher risk of developing Leukemia. Now researchers from the University of Copenhagen explain why, by identifying specific changes in blood cells of people with Down’s syndrome.

Lars Engelholm awarded prestigious grant to advance innovative pan-cancer therapy

Patients suffering from pancreatic cancer, as well as other cancer types, may face better treatment in the future. Researchers from BRIC and Rigshospitalet are awarded a 5 million DKK Frontier Grant by LF.